Staff can easily become confused about vaccines within the storage unit because there are so many brands and formulations 

available. Labeling the area where vaccines are stored can help staff quickly locate and choose the correct vaccine with the goal of

preventing a vaccine administration error. Depending on how vaccines are organized within the storage unit, labels can be placed 

on containers or bins or directly attached to shelves where vaccines are placed. Other helpful strategies to prevent vaccine 

administration errors include color-coding labels (e.g., one color for pediatric and another for adult vaccines) and providing 

additional information such as age indications or other information unique to the vaccine.

In addition, some vaccines must be reconstituted before administration. These vaccines have two components—a lyophilized 

vaccine and a diluent that must be mixed together. The lyophilized vaccine should only be reconstituted or mixed using the 

diluent supplied by the manufacturer. Consider posting reminders or labeling vaccines to remind staff to reconstitute certain 

vaccines prior to administration.

The following labels are examples that may be used to help organize vaccines. Labels are based on recommendations from

the Advisory Committee on Immunization Practices (ACIP) and may include indications different from those of the Food and 

Drug Administration. The Centers for Disease Control and Prevention (CDC) also recommends vaccines be stored in the 

original packaging to protect the contents from light, to help maintain the recommended temperature range, and to help prevent 

administration errors.

Note: Some vaccine preparations are being transitioned from vials and prefilled syringes that contain natural rubber latex to vials 

and prefilled syringes that are not made with natural rubber latex. Read the package insert that accompanies the product to check 

for the presence of natural rubber latex.

 Updated 10/17/2023

Vaccine Label Examples
DENGVAXIA

(Live Dengue Vaccine)

● Lyophilized Powder Vaccine Antigen Vial

● Saline Diluent Vial

Ages: 9 yearsthrough 16 years(with laboratory-confirmed previous 

dengue infection and living in dengue-endemic areas)

Dosage: 0.5 mL each, 6 months apart (at 0, 6, and 12) 

Route: Subcutaneous (SUBCUT) injection

Protect From Light 

Do Not Freeze

Reconstitute ONLY with 0.6 mL of manufacturer-supplied 0.9⁒ saline diluent 

Withdraw 0.5 mL for administration

After reconstitution, administer immediately or store at 2°C to 8°C (36°F to 46°F) 

and use within 30 minutes

Dengue
Diphtheria- and Tetanus-Toxoid- and acellular Pertussis-Containing Vaccines

Ages:

DTaP (Infanrix)

6 weeks through 6 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

DTaP-IPV-HepB (Pediarix)

Ages: 6 weeks through 6 years

Use for: DTaPandIPV:Doses#1,#2,and/or#3 

HepB: Any dose in the series

Do NOT use for HepB birth dose

Route: Intramuscular (IM) injection

Ages:

DTaP-IPV (Kinrix)

4 years through 6 years

Use for: DTaP dose #5

IPV dose #4

Do NOT use for DTaP doses 1 

through 4 OR IPV doses 1 through 3

Route: Intramuscular (IM) injection

Ages:

DTaP (Daptacel)

6 weeks through 6 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection
Diphtheria- and Tetanus-Toxoid- and acellular Pertussis-Containing Vaccines

Ages:

DTaP-IPV (Quadracel)

4 years through 6 years

Use for: DTaP dose #5

IPV dose #4 or #5

Do NOT use for DTaP doses 1 

through 4 OR IPV doses 1 through 3

Route: Intramuscular (IM) injection

DTaP-IPV-HepB-Hib (Vaxelis)

Ages: 6 weeks through 4 years

Use for: DTaP and IPV: Doses #1, #2, and/or

#3

Hep B: Any dose in the series

(Do NOT use for HepB birth dose)

Hib: Any dose in the series

Route: Intramuscular (IM) injection

DTaP-IPV-Hib (Pentacel)

Ages: 6 weeks through 4 years

Use for: DTaP and IPV: Doses #1, #2, 

#3, and/or #4

Hib: Any dose in the series

Route: Intramuscular (IM) injection

Reconstitute Hib powder ONLY with 

manufacturer-supplied DTaP-IPV liquid diluent

Use immediately after reconstitution

Do NOT administer DTaP-IPV w/o Hib
Haemophilus influenzae type b-Containing Vaccines

Ages:

Hib (Hiberix)

6 weeks through 4 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Reconstitute Hib powderONLYwith manufacturersupplied 0.9%sodium chloride diluent

Beyond Use Time: If not used immediately afterreconstitution, 

store at 2°C to 8°C (36°F to 46°F) and discard if not used within 

24 hours. Shake well priorto administration.

Ages:

Hib (PedvaxHIB)

6 weeks through 4 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Ages:

Hib (ActHIB)

6 weeks through 4 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Reconstitute Hib powderONLYwith manufacturersupplied 0.4% sodium chloride diluent

Beyond UseTime:If not usedimmediately afterreconstitution, store 

at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.

Shake well priorto administration.
Hepatitis Vaccines

HepA(Vaqta)-Pediatric Formulation

Ages: 12 months through 18 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

HepB (Recombivax HB)-Pediatric

Formulation

Ages: Birth through 19 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

HepB (Engerix-B)-Pediatric Formulation

Ages: Birth through 19 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection

HepA(Havrix)-Pediatric Formulation

Ages: 12 months through 18 years

Use for: Any dose in the series

Route: Intramuscular (IM) injection
Hepatitis Vaccines

HepA (Vaqta)-Adult Formulation

Ages: 19 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection

HepB (Recombivax HB)-Adult

Formulation

Ages:

Use for:

20 years and older

Any dose in the series

AlternateAdolescent Schedule for 11-through 15 -year olds:

Two 1 mL doses 4 to 6 months apart

Route: Intramuscular (IM) injection

HepB (Engerix-B)-Adult Formulation

Ages: 20 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection

HepA (Havrix)-Adult Formulation

Ages: 19 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection
Hepatitis Vaccines

Ages:

HepB (PreHevbrio)

18 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Ages:

HepA-HepB (Twinrix)

18 years and older

Contains: HepA = Pediatric dosage

HepB = Adult dosage

Schedule: 0, 1, and 6 months

Alternate Schedule: 0, 7, and 21 to 30 

days, followed by booster at 12 months

Route: Intramuscular (IM) injection

Ages:

HepB (Heplisav-B)

18 years and older

Use for: Any dose in the series (two 0.5 mL

 doses 1 month apart)

Route: Intramuscular (IM) injection
Human Papillomavirus Vaccines

9vHPV (Gardasil 9)

Ages: 9 years through 45 years

Recommended ages: 11 years or 12 years

Catch-up ages: 13 years through 26 years

Shared clinical decision-making ages: 27 

through 45 years

Route: Intramuscular (IM) injection
Ages:

MMR (M-M-R II)

12 months and older

Use for: Any dose in the series

Route: Subcutaneous (subcut) injection

Reconstitute MMR powder ONLY with 

manufacturer-supplied sterile water diluent

Beyond Use Time: If not used immediately afterreconstitution, 

store in vaccine vial in dark place at 2°C to 8°C (36°F to 46°F) 

and discard if not used within 8 hours.

Measles, Mumps, Rubella Vaccine
Meningococcal Vaccines

MenACWY-TT (MenQuadfi)

Ages: 2 years and older

Use for: Any dose in the series (and certain

 high-risk groups)

Route: Intramuscular (IM) injection

Do NOT Freeze

MenACWY-D (Menactra)

Ages: 9 months and older

Use for: Any dose in the series (and certain 

high-risk groups)

Route: Intramuscular (IM) injection

Do NOT Freeze
Meningococcal Vaccines

Ages: 2 months and older

Use for: Any dose in the series 

 MenACWY-CRM (Menveo)

Two-Vial (Reconstitution Required)

 Orange Cap Vial (MenA) Gray Cap Vial (CWY)

Route: Intramuscular (IM) injection

Reconstitute the MenA lyophilized conjugate component ONLY with 

manufacturer-supplied MenCWY liquid conjugate component.

Do NOT administer MenCWY without MenA

Do NOT Freeze

Beyond Use Time: Use immediately afterreconstitution. May be stored between

2° and 25°C (36° and 77°F) for up to 8 hours.

Route: Intramuscular (IM) injection

MenACWY-CRM (Menveo)

Single-Vial (Ready-to-Use)

Pink Cap Vial

 Ages: 10 years and older

 Use for: Any dose in the series 

Do NOT Freeze
Meningococcal Vaccines

MenB-FHbp (Trumenba)

Ages: 10 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Bexsero and Trumenba are NOT interchangeable 

Complete series with same vaccine product

Ages:

MenB-4C (Bexsero)

10 years and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Bexsero and Trumenba are NOT interchangeable 

Complete series with same vaccine product
PCV15 (Vaxneuvance)

Ages: 6 weeks and older

Use For: Any dose in the series

Route: Intramuscular (IM) injection

PCV20 (Prevnar 20)

Ages: 6 weeks and older

Use For: Any dose in the series

Route: Intramuscular (IM) injection

PCV13 (Prevnar 13)

Ages: Children 6 weeks through 5 years

Certain high-risk groups 6 years through 18 

years who have never received PCV13 or 

received an incomplete PCV13 series

Route: Intramuscular (IM) injection

PPSV23 (Pneumovax 23)

Ages: Persons aged 2 through 64 years with 

certain risk conditions or adults 65 

years and older with indications

Use for: After PCV15 dose

Route: Intramuscular (IM) injection OR

Subcutaneous (subcut) injection

Pneumococcal Vaccines

Do NOT Freeze

Do NOT Freeze

Do NOT Freeze

Do NOT Freeze
Ages:

IPV

6 weeks and older

Use for: Any dose in the series

Route: Intramuscular (IM) injection OR

Subcutaneous (subcut) injection

Poliovirus Vaccine
RV1 (Rotarix)

Vial plus Oral Applicator

 

Ages: 6 weeks through 8 months, 0 days 

Doses: Two 

 Maximum age for 1st dose - 14 weeks, 6 days 

 Maximum age for last dose - 8 months, 0 days

Route: Oral (PO)

Reconstitute RV1 powder ONLY with manufacturer-supplied 

sterile water/calcium carbonate/xanthan diluent

Do NOT Inject

Do NOT Freeze

Beyond Use Time: If not used immediately after reconstitution, store at

2°C to 8°C (36°F to 46°F) or at controlled room temperature up to 25°C

(77°F) and discard if not used within 24 hours.

RV1 (Rotarix)

 Single Oral Applicator (Ready-to-use)

Ages: 6 weeks through 8 months, 0 days 

Doses: Two

Maximum age for 1st dose -14 weeks, 6 days

Maximum age for last dose - 8 months, 0 days

Route: Oral (PO)

Do NOT Inject

Do NOT Freeze

Rotavirus Vaccines
RV5 (RotaTeq)

Ages: 6 weeks through 8 months, 0 days 

Doses: Two

 Maximum age for 1st dose - 14 weeks, 6 days 

 Maximum age for last dose is 8 months, 0 days

Route: Oral (PO)

Do NOT inject

Rotavirus Vaccines
 RSV (Pfizer/ABRYSVO)

Ages: 60 years and older

 Pregnant people at 32-36 weeks gestation

Route: Intramuscular (IM) injection

Reconstitute RSV powder ONLY with 

manufacturer-supplied sterile water diluent

Do Not Freeze

Beyond UseTime:If not used immediately after reconstitution, store

at room temperature [15°C to 30°C(59°Fto 86°F)] and discard ifnot

usedwithin 4 hours.

 RSV (GSK/AREXVY)

Ages: 60 years and older

Route: Intramuscular (IM) injection

Reconstitute RSV powder ONLY with 

manufacturer-supplied adjuvant suspension

Do Not Freeze

Beyond UseTime:If not used immediately after reconstitution, store 

refrigerated at 2°Cto 8°C(36°Fto 46°F) or at room temperature up to 

25°C(77°F). Discard ifnotused within 4 hours.

Respiratory Syncytial Virus (RSV)
Ages:

DT (generic)

6 weeks through 6 years

Use for: Primary series and booster doses

ONLY for children with a 

contraindication or precaution to 

pertussis vaccine

Route: Intramuscular (IM) injection

Ages:

Td (generic)

7 years and older

Use for: Primary series and booster doses

for persons previously vaccinated with Tdap

Route: Intramuscular (IM) injection

Ages:

Td (Tenivac)

7 years and older

Use for: Primary series and booster doses

for persons previously vaccinated with Tdap

Route: Intramuscular (IM) injection

Tetanus- and Diphtheria-Toxoid-Containing Vaccines
Tdap (Adacel)

Ages: 7 years and older

Use for: Routine adolescent dose at 11 to 12 

years of age

Each pregnancy

Patients not fully vaccinated for 

pertussis

Route: Intramuscular (IM) injection

Tdap (Boostrix)

Ages: 7 years and older

Use for: Routine adolescent dose at 11 to 12 

years of age

Each pregnancy

Patients not fully vaccinated for 

pertussis

Route: Intramuscular (IM) injection

Tetanus- and Diphtheria-Toxoid- and acellular Pertussis-Containing Vaccines
Ages:

VAR (Varivax)

12 months and older

Use for: Any dose in the series

Route: Subcutaneous (subcut) injection

Reconstitute VAR powder ONLY with

manufacturer-supplied sterile water diluent

Beyond Use Time: Discard reconstituted vaccine if not used 

within 30 minutes.

Ages:

MMRV (ProQuad)

12 months through 12 years

Use for: Any dose in the series

Route: Subcutaneous (subcut) injection

Reconstitute MMRV powder ONLY with

manufacturer-supplied sterile water diluent

Beyond Use Time: Discard reconstituted vaccine if not used 

within 30 minutes.

Frozen Varicella-Containing Vaccines
RZV (Shingrix)

Ages: Adults 50 years and older

Adults 19 years and older who are or will be 

immunodeficient or immunosuppressed because of disease 

or therapy

Use for: Any dose in the series

Route: Intramuscular (IM) injection

Refrigerate both components; do NOT freeze

Reconstitute lyophilized varicella zoster component 

with manufacturer-supplied adjuvant suspension 

Beyond UseTime: Discard reconstituted vaccine if not used within

6 hours.

Refrigerated Varicella-Containing Vaccine
Reconstituted Vaccines

MMR (M-M-R II)

+ =

Lyophilized Manufacturer’s

MMR component sterile water diluent

M-M-R II

vaccine

Beyond Use Time: If not used immediately after reconstitution, store in vaccine vial 

in dark place at 2°C to 8°C (36°F to 46°F) and discard if not used within 8 hours.

Hib (Hiberix)

+ =

Lyophilized Hib Manufacturer’s 0.9% 

component sodium chloride diluent

Hiberix 

vaccine

Beyond Use Time: If not used immediately afterreconstitution, 

store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.

Should be shaken vigorously before injection.

Hib (ActHIB)

+ =

Lyophilized

Hib component

Manufacturer’s 0.4% 

sodium chloride diluent

ActHIB vaccine

Beyond Use Time: If not used immediately after reconstitution, 

store at 2°C to 8°C (36°F to 46°F) and discard if not used within 24 hours.

Should be shaken vigorously before injection.

DTaP-IPV/HIB (Pentacel)

+ =

Lyophilized Hib Manufacturer’s DTaPcomponent IPV liquid componentPentacel 

vaccine

Should be used immediately after reconstitution
Reconstituted Vaccines

RV1 (Rotarix)

+ =

Lyophilized RV1 Manufacturer’s sterile watercomponent calcium carbonate-xanthan diluent

Rotarix vaccine

Do NOT inject

Beyond Use Time: If not used immediately after reconstitution,

store at 2°C to 8°C (36°F to 46°F) or at controlled room temperature up to 25°C (77°F) 

and discard if not used within 24 hours.

MenACWY-CRM (Menveo)

+

Lyophilized

MenA component

=

MenCWY liquid 

component

Menveo 

vaccine

Beyond Use Time: Should be used immediately after reconstitution, but may be 

stored at or below 25°C (77°F) and discarded if not used within 8 hours.
Reconstituted Vaccines

MMRV (ProQuad)

+

Lyophilized MMRV

component

=

Manufacturer’s

sterile water diluent

ProQuad 

vaccine

Beyond Use Time: Discard reconstituted vaccine if not used 

within 30 minutes.

RZV (Shingrix)

+ =

Lyophilized varicella Manufacturer’s

zoster component adjuvant suspension

Shingrix 

vaccine

Refrigerate both components; do NOT freeze

Beyond Use Time: Discard reconstituted vaccine if not used within 6 hours.

VAR (Varivax)

+ =

Lyophilized VAR Manufacturer’s 

component sterile water diluent

Varivax 

vaccine

Beyond Use Time: Discard reconstituted vaccine if not used 

within 30 minutes.